Growth Differentiation Factor-15 Linked to Transplant-Free Survival in PH
Investigators sought to determine whether growth differentiation factor-15 is a significant prognostic biomarker in pulmonary hypertension.
Pulmonary Hypertension
Balloon Pulmonary Angioplasty Effective for Chronic Thromboembolic PH
For patients with inoperable or residual postendarterectomy chronic thromboembolic pulmonary hypertension, performing a balloon pulmonary angioplasty provided improvements in pressure measurements, functional class, and exercise capacity with an acceptable risk profile.
Pulmonary Hypertension Linked to Mortality After Atrial Septal Defect Repair
Persistent pulmonary hypertension is strong predictor of mortality in older patients who underwent ASD closure.
FDA to Review Drug-Device Combo for Pulmonary Arterial Hypertension Treatment
The FDA has accepted for review the New Drug Application for Trevyent, a drug-device combination product for the treatment of pulmonary arterial hypertension.
Sotatercept Receives Orphan Drug Status for Pulmonary Arterial Hypertension
The FDA has granted Orphan Drug designation to sotatercept for the treatment of patients with pulmonary arterial hypertension.
New Pulmonary Hypertension Definition Clarifies Mortality Risk After Heart Transplant
The new definition of pulmonary hypertension has demonstrated validity in a study recently published in CHEST, which showed an association between elevated pulmonary vascular resistance (PVR) and increased risk for mortality within 30 days of heart transplant. This risk can be sustained even with lower pulmonary arterial pressures. This retrospective study included 32,465 adult participants…
Ralinepag Reduces Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension
Treatment with the next-generation potent prostacyclin receptor agonist ralinepag reduced pulmonary vascular resistance compared with placebo in patients with symptomatic pulmonary arterial hypertension.
Clinical Case: Dyspnea on Exertion After Complications From Chemotherapy
A 65-year-old woman with breast cancer and hypertension has been experiencing progressive dyspnea on exertion after complications from chemotherapy.
Effects of Pulmonary Hypertension on Outcomes After MVR for Rheumatic Mitral Stenosis
Researchers gauged the effect of concomitant pulmonary hypertension on clinical outcomes and late-onset progression of tricuspid regurgitation after mitral valve relapse for rheumatic mitral stenosis.
Pulmonary Arterial Hypertension in Women: New Approaches to Care
Investigators provide recent information on the classification, pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension, focusing specifically on its impact on women.
Next post in Pulmonary Hypertension
